STEPHANIE TYSON: Open Payments
NPI 1437683224 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 70 payments from 17 companies in 2025. Trend: 2023 $93 · 2024 $517 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $174 |
| AstraZeneca Pharmaceuticals LP | 7 | $157 |
| ABBVIE INC. | 26 | $154 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: VRAYLAR, FANAPT, Wegovy, XIFAXAN, Ozempic, FARXIGA, BREZTRI, REXULTI.
Industry payments across GA — which companies pay providers there.
